Neuropsychological approaches to treatment policy issues in phenylketonuria

European Journal of Pediatrics, Supplement

Volumn 159, Issue 2, 2000, Pages

  Griffiths, P ^a  

^a UNIVERSITY OF STIRLING   (United Kingdom)

Author keywords

Diet therapy; Neuropsychological assessment; Phenylketonuria; Treatment policy

Indexed keywords

PHENYLALANINE;

AMINO ACID BLOOD LEVEL; CHILD DEVELOPMENT; CONFERENCE PAPER; DIET RESTRICTION; DIET THERAPY; DISEASE COURSE; HUMAN; HYPERPHENYLALANINEMIA; NEUROPSYCHOLOGICAL TEST; PHENYLKETONURIA; POLICY; PRACTICE GUIDELINE; PRIORITY JOURNAL;

EID: 0033826901     PISSN: 09439676     EISSN: None     Source Type: Journal    
DOI: 10.1007/pl00014390     Document Type: Conference Paper

References (39)

1. Termination of strict diet in phenylketonuria
2. Neuropsychological assessment
3. Phenylketonuria and sustained attention: The continuous performance test
4. Neuropsychologic functions of early treated patients with phenylketonuria, on and off diet: Results of a cross-national and cross-sectional study
5. Rationale for the German recommendations for phenylalanine level control in phenylketonuria 1997
6. Neuropsychological studies on adolescents with phenylketonuria returned to phenylalanine-restricted diets
7. Phenylalanine levels of 6-10mg/dl may not be benign as once thought
8. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU
9. Neuropsychological functioning in treated phenylketonuria
10. Neuropsychological effects of subsequent exposure to phenylalanine in adolescents and young adults with early-treated phenylketonuria
11. Executive function and psychosocial adjustment in children with early treated phenylketonuria: Correlation with historical and concurrent phenylalanine levels
12. Executive function in treated phenylketonuria as measured by the one-back and two-back versions of the continuous performance test
13. Neuropsychological outcome of experimental manipulation of phenylalanine intake in treated phenylketonuria
14. Perceptual-motor functioning in children with phenylketonuria
15. Biochemical and neuropsychological effects of elevated plasma phenylalanine in patients with treated phenylketonuria
16. Decreased vigilance and neurotransmitter synthesis after discontinuation of dietary treatment for phenylketonuria in adolescents
17. Increased vigilance and dopamine synthesis by large doses of tyrosine or phenylalanine restriction in phenylketonuria
18. An occipito-temporal syndrome in adolescents with optimally controlled hyperphenylalaninaemia
19. Cognitive development among children with early-treated phenylketonuria
20. Recommendations on the dietary management of phenylketonuria
21. Neuropsychological deficits in early-treated phenylketonuric children
22. EEGs in phenylketonuria: Follow-up to adulthood and short-term diet-related changes in EEGs and cognitive function
23. 1H magnetic resonance spectroscopy
24. Psychiatric diagnosis and behavioral characteristics of phenylketonuric children
25. Early-treated phenylketonuria: Adult neuropsychologic outcome
26. Sustained attention in adult phenylketonuria: The influence of the concurrent phenylalanine blood-level
27. Loss of intellectual function in children with phenylketonuria after relaxation of dietary phenylalanine restriction
28. Randomised controlled trial of tyrosine supplementation on neuropsychological performance in phenylketonuria
29. A test of the frontal specificity hypothesis in the congnitive performance of adults with phenylketonuria
30. Information processing in early-treated PKU
31. Information processing deficits in children with early and continuously treated phenylketonuria?
32. My experience of PKU
33. Brain MRI changes in phenylketonuria - Associations with dietary status
34. Effect of L-dopa on visual evoked potentials and neuropsychological tests in adult phenylketonuria patients
35. Neurological deterioration in adult phenylketonuria
36. Deficits in selective and sustained attention processes in early-treated children with phenylketonuria
37. Neuropsychology of early-treated phenylketonuria: Specific executive function deficits